^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    lisaftoclax (APG-2575)

    i
    Other names: APG-2575, APG2575, APG 2575
    Company:
    Ascentage Pharma
    Drug class:
    Bcl2 inhibitor
    Related drugs:
    10ms
    Ailawadhi et al report on safety, efficacy, #pharmacokinetics, and #pharmacodynamics of #lisaftoclax, a novel, selective BCL-2 inhibitor in patients with relapsed or refractory chronic #LymphocyticLeukemia and other hematologic malignancies. @DrMDavids (@CCR_AACR)
    Clinical • PK/PD data
    |
    lisaftoclax (APG-2575)
    almost3years
    #AscentagePharma Announces #IND Clearance by the US #FDA for #Lisaftoclax (#APG2575) as Single Agent or in Combinations for the Treatment of #ERPositive #BreastCancer and Other #SolidTumors https://t.co/kH1dKbsZLs (@1stOncology)
    ER (Estrogen receptor)
    |
    ER positive
    |
    lisaftoclax (APG-2575)